STOCKWATCH
·
Commodity Chemicals
Partnership11 Jul 2025, 03:46 pm

Fischer Medical Ventures Partners with City of Jember to Eradicate Tuberculosis in Indonesia by 2026

AI Summary

Fischer Medical Ventures Ltd (FMV) has announced a public-private partnership with the City of Jember, Indonesia, to support tuberculosis eradication through AI-powered portable X-ray systems. The initiative, valued at over USD 10 million, aims to deploy portable, AI-powered X-ray systems to help 'Free Tuberculosis (TB) in Jember' by 2026. This move is strategic for FMV as Indonesia continues to battle one of the highest burdens of TB in the world. The partnership aims to put citizens at the center, ensuring access to early detection, timely treatment, and sustained care.

Key Highlights

  • Fischer Medical Ventures Ltd (FMV) has partnered with the City of Jember, Indonesia, to deploy portable, AI-powered X-ray systems aimed at eradicating tuberculosis by 2026.
  • The initiative is a strategic move by FMV into Indonesia's healthcare market, combining innovation, access, and impact to transform public health outcomes.
  • The program is estimated to be over USD 10 million with an implementation plan over 2 years in multiple phases.
  • The partnership aims to ensure citizens gain access to early detection, timely treatment, and sustained care.
  • FMV's comprehensive TB solution is changing lives—one patient, one diagnosis at a time, starting with Jember city.
FISCHER
Commodity Chemicals
FISCHER CHEMIC LTD.

Price Impact